3D Pancreatic Beta Cell Culture for High-Throughput Screening
Find Innovative SolutionsGenerate Solutions
Solution Overview
Problem
Conventional two-dimensional (2D) cell-culture systems fail to mimic in vivo conditions, while existing three-dimensional (3D) culture systems lack the simplicity and throughput necessary for high-throughput screening of compounds.
Innovation Solution
A device comprising a polymer membrane with a mold and pedestal is used to create discrete 3D cell cultures, allowing for high-throughput screening of perturbations in a 3D cell-culture environment, with each volume containing up to 90,000 cells and a thickness of 5 μm to 600 μm, capable of mimicking in vivo environments and supporting cell functions like insulin secretion.
Engineering Contradictions & Design Principles
Engineering Contradiction Analysis
1Productivity
If conventional two-dimensional cell-culture systems are used, then the simplicity and throughput for screening are maintained, but the ability to mimic in vivo conditions is lost
Solution Approach 1:
The patent transitions from two-dimensional cell culture to three-dimensional cell culture by forming cell aggregates or spheroids in suspension. This dimensional change allows cells to self-organize into structures that better mimic in vivo tissue architecture and cellular interactions, thereby improving the reliability of in vivo condition simulation while maintaining compatibility with high-throughput screening formats through the use of multi-well plates.
2Reliability
If conventional three-dimensional culture systems are used, then the morphological and biological complexity is preserved, but the simplicity and throughput for high-throughput screening are lost
Solution Approach 1:
The patent segments the three-dimensional cell culture system into discrete, standardized units that can be individually manipulated and screened. By forming distinct cell aggregates that can be handled as separate entities in multi-well plates, the system maintains the biological complexity of 3D cultures while enabling high-throughput screening through standardized, simplified操作流程.
Solution Approach 2:
The patent optimizes key parameters such as cell density, aggregate size, and culture conditions to achieve a balance between maintaining 3D structural complexity and enabling high-throughput screening. By controlling these parameters, the system preserves morphological and biological complexity while ensuring compatibility with automated screening platforms.
3Reliability
If larger three-dimensional cell cultures are formed, then the in vivo environment mimicry is improved, but the throughput and screening efficiency are reduced
Solution Approach 1:
The patent optimizes the size and composition parameters of cell aggregates to achieve an optimal balance. By controlling cell density, aggregate diameter, and thickness, the system maintains sufficient 3D structural complexity for in vivo mimicry while keeping the physical dimensions small enough to accommodate high-throughput screening formats in multi-well plates.
Data Source
AI summary
3D cell cultures and devices for 3D cell culture, and methods of use thereof are provided. In some embodiments, the 3D cell culture comprise pancreatic β cells and can be generated in multi-well plates, allowing for high throughput assays on the cell culture.